Tianda Pharmaceuticals Limited (HKG:0455)
0.0990
-0.0020 (-1.98%)
At close: Mar 10, 2026
Tianda Pharmaceuticals Market Cap
Tianda Pharmaceuticals has a market cap or net worth of 212.85 million as of March 10, 2026. Its market cap has decreased by -46.49% in one year.
Market Cap
212.85M
Enterprise Value
249.67M
Revenue
310.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since October 27, 1993, Tianda Pharmaceuticals's market cap has decreased from 315.36M to 212.85M, a decrease of -32.50%. That is a compound annual growth rate of -1.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 217.15M | -21.71% |
| Dec 31, 2025 | 277.36M | -23.67% |
| Dec 31, 2024 | 363.36M | -22.48% |
| Dec 29, 2023 | 468.71M | -46.17% |
| Dec 30, 2022 | 870.77M | 26.56% |
| Dec 31, 2021 | 688.01M | 131.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusen Pharmaceutical Company | 791.05M |
| Pak Fah Yeow International | 729.24M |
| Zhongzhi Pharmaceutical Holdings | 690.88M |
| China NT Pharma Group Company | 492.20M |
| Wai Yuen Tong Medicine Holdings | 365.66M |
| Regent Pacific Group | 262.63M |
| Shenzhen Neptunus Interlong Bio-technique Company | 246.67M |
| Extrawell Pharmaceutical Holdings | 198.90M |